Literature DB >> 23534779

Clinico-pathological profile of lung cancer at AIIMS: a changing paradigm in India.

Prabhat Singh Malik1, Mehar Chand Sharma, Bidhu Kalyan Mohanti, N K Shukla, Svs Deo, Anant Mohan, Guresh Kumar, Vinod Raina.   

Abstract

BACKGROUND: Lung cancer is one of the commonest and most lethal cancers throughout the world. The epidemiological and pathological profile varies among different ethnicities and geographical regions. At present adenocarcinoma is the commonest histological subtype of non-small cell lung cancer (NSCLC) in most of the Western and Asian countries. However, in India squamous cell carcinoma has been reported as the commonest histological type in most of the series. The aim of the study was to analyze the current clinico-pathological profile and survival of lung cancer at our centre.
MATERIALS AND METHODS: We analyzed 434 pathologically confirmed lung cancer cases registered at our centre over a period of three years. They were evaluated for their clinical and pathological profiles, treatment received and outcome. The available histology slides were reviewed by an independent reviewer.
RESULTS: Median age was 55 years with a male:female ratio of 4.6:1. Some 68% of patients were smokers. There were 85.3% NSCLC and 14.7% SCLC cases. Among NSCLCs, adenocarcinoma was the commonest histological subtype after the pathology review. Among NSCLC, 56.8% cases were of stage IV while among SCLC 71.8% cases had extensive stage disease. Some 29% of patients could not receive any anticancer treatment. The median overall and progression free survivals of the patients who received treatment were 12.8 and 7.8 months for NSCLC and 9.1 and 6.8 months for SCLC.
CONCLUSIONS: This analysis suggests that adenocarcinoma may now be the commonest histological subtype also in India, provided a careful pathological review is done. Most of the patients present at advanced stage and outcome remains poor.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23534779     DOI: 10.7314/apjcp.2013.14.1.489

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  22 in total

1.  Accelerated hypofractionated radiotherapy with concomitant chemotherapy in locally advanced squamous cell carcinoma of lung: evaluation of response, survival, toxicity and quality of life from a Phase II randomized study.

Authors:  Soumyajit Roy; Sushmita Pathy; Bidhu K Mohanti; Vinod Raina; Anand Jaiswal; Rakesh Kumar; Mani Kalaivani
Journal:  Br J Radiol       Date:  2016-03-17       Impact factor: 3.039

2.  Association of p53 and mdm2 in the development and progression of non-small cell lung cancer.

Authors:  Jamsheed Javid; Rashid Mir; P K Julka; P C Ray; Alpana Saxena
Journal:  Tumour Biol       Date:  2015-02-12

3.  Role of survivin re-expression in the development and progression of non-small cell lung cancer.

Authors:  Jamsheed Javid; Rashid Mir; P K Julka; P C Ray; Alpana Saxena
Journal:  Tumour Biol       Date:  2015-02-14

4.  An Immunohistochemical Study of Anaplastic Lymphoma Kinase and Epidermal Growth Factor Receptor Mutation in Non-Small Cell Lung Carcinoma.

Authors:  Sonal Verma; Madhu Kumar; Malti Kumari; Raj Mehrotra; R A S Kushwaha; Madhumati Goel; Ashutosh Kumar; Surya Kant
Journal:  J Clin Diagn Res       Date:  2017-07-01

Review 5.  Translatable gene therapy for lung cancer using Crispr CAS9-an exploratory review.

Authors:  Jishnu Nair; Abhishek Nair; Soundaram Veerappan; Dwaipayan Sen
Journal:  Cancer Gene Ther       Date:  2019-06-20       Impact factor: 5.987

6.  Lung cancer: prevalent trends & emerging concepts.

Authors:  Prabhat Singh Malik; Vinod Raina
Journal:  Indian J Med Res       Date:  2015-01       Impact factor: 2.375

7.  Clinical and epidemiological study of EGFR mutations and EML4-ALK fusion genes among Indian patients with adenocarcinoma of the lung.

Authors:  Dc Doval; K Prabhash; S Patil; H Chaturvedi; C Goswami; Ak Vaid; S Desai; S Dutt; Vh Veldore; N Jambhekar; A Mehta; D Hazarika; S Azam; S Gawande; S Gupta
Journal:  Onco Targets Ther       Date:  2015-01-05       Impact factor: 4.147

8.  Evaluation of epidermal growth factor receptor mutations based on mutation specific immunohistochemistry in non-small cell lung cancer: A preliminary study.

Authors:  Deepali Jain; Sobuhi Iqbal; Ritika Walia; Prabhat Malik; Sunu Cyriac; Sandeep R Mathur; Mehar C Sharma; Karan Madan; Anant Mohan; Ashu Bhalla; Sushmita Pathy; Lalit Kumar; Randeep Guleria
Journal:  Indian J Med Res       Date:  2016-03       Impact factor: 2.375

Review 9.  Lung cancer in the Indian subcontinent.

Authors:  Vanita Noronha; Rakesh Pinninti; Vijay M Patil; Amit Joshi; Kumar Prabhash
Journal:  South Asian J Cancer       Date:  2016 Jul-Sep

10.  Epidermal growth factor receptor mutation in lung adenocarcinoma in India: A single center study.

Authors:  Dinesh Chandra Doval; Saud Azam; Ullas Batra; Kumardeep Dutta Choudhury; Vineet Talwar; Sunil Kumar Gupta; Anurag Mehta
Journal:  J Carcinog       Date:  2013-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.